Literature DB >> 6653297

Failure of new diagnostic aids in improving detection of pancreatic cancer at a resectable stage.

V Savarino, C Mansi, L Bistolfi, P Zentilin, G Celle.   

Abstract

This study was undertaken to verify whether new diagnostic tools (angiography, endoscopic retrograde cholangiopancreatography, ultrasonography, and computed tomography) have improved the detection of pancreatic cancer at a resectable stage. Two groups of patients with histologically ascertained cancer of the pancreas were examined. The first consisted of 54 cases investigated before the clinical application of the four above-mentioned techniques and the second of 74 cases investigated thereafter. Cancer resectability was judged by a surgical team at the time of laparotomy according to preestablished criteria. No significant difference was found between the number of resections and other procedures in the two groups. On the other hand exploratory laparotomies performed exclusively for diagnostic purposes were significantly (P less than 0.01) reduced in the second group. On the basis of these results one may conclude that new diagnostic aids are useful and reliable in the preoperative detection of pancreatic cancer, but their introduction into clinical practice has not permitted an earlier diagnosis of the disease and therefore there has been no important increase in its resectability.

Entities:  

Mesh:

Year:  1983        PMID: 6653297     DOI: 10.1007/BF01295805

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  Comparison of ultrasound and computer-assisted tomography in pancreatic diagnosis.

Authors:  J E Husband; H B Meire; L Kreel
Journal:  Br J Radiol       Date:  1977-12       Impact factor: 3.039

2.  Surgical principles for pancreatic cancer: regional total and subtotal pancreatectomy.

Authors:  J G Fortner
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860

3.  Percutaneous fine needle aspiration biopsy of intra-abdominal lesions with ultrasound guidance.

Authors:  H C Yeh
Journal:  Am J Gastroenterol       Date:  1981-02       Impact factor: 10.864

4.  Differential diagnosis of pancreatic mass lesion with percutaneous fine-needle aspiration biopsy under ultrasonic guidance.

Authors:  T Yamanaka; K Kimura
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

5.  Correlative evaluation of angiography and pancreatoductography in relation to surgery for cancer of the pancreas.

Authors:  T Suzuki; M Imamura; K Tamura; A Sumiyoshi; S Sakanashi; Y Nishimura; T Tobe
Journal:  Surgery       Date:  1979-06       Impact factor: 3.982

6.  The diagnostic accuracy of gray-scale ultrasonography compared with ERP and arteriography in the detection of pancreatic carcinoma.

Authors:  I Suramo; J Lehtola; A Leinonen; M Kairaluoma
Journal:  Scand J Gastroenterol       Date:  1979       Impact factor: 2.423

7.  Comparison of ultrasound pancreatic scanning and encoscopic retrograde cholangiopancreatograms: a retrospective study.

Authors:  S B Feinberg; D R Schreiber; R Goodale
Journal:  J Clin Ultrasound       Date:  1977-04       Impact factor: 0.910

8.  Ultrasound-guided percutaneous fine-needle aspiration cytology in pancreatic cancer.

Authors:  N Hovdenak; W R Lees; J Pereira; J O Beilby; P B Cotton
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-23

9.  Value of new diagnostic aids in relation to the disease process in pancreatic cancer.

Authors:  C R Mackie; J Dhorajiwala; M O Blackstone; J Bowie; A R Moossa
Journal:  Lancet       Date:  1979-08-25       Impact factor: 79.321

10.  Evaluation of endoscopic retrograde cholangiopancreatography and angiography in the diagnosis of pancreatic carcinoma.

Authors:  P C Freeny; T J Ball
Journal:  AJR Am J Roentgenol       Date:  1978-04       Impact factor: 3.959

View more
  5 in total

1.  Diagnosing cancer of the pancreas.

Authors:  J N Thompson
Journal:  BMJ       Date:  1990-10-06

Review 2.  Pancreatic cancer in 1988. Possibilities and probabilities.

Authors:  A L Warshaw; R S Swanson
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

3.  Beta human chorionic gonadotropin concentrations in serum of patients with pancreatic adenocarcinoma.

Authors:  K N Syrigos; I Fyssas; M M Konstandoulakis; K J Harrington; S Papadopoulos; N Milingos; P Peveretos; B C Golematis
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

Review 4.  Diabetes mellitus: a risk factor for pancreatic cancer?

Authors:  M Yalniz; P M Pour
Journal:  Langenbecks Arch Surg       Date:  2004-04-09       Impact factor: 3.445

Review 5.  Hormonal therapy of pancreatic carcinoma. Rationale and perspectives.

Authors:  D Perilli; C Mansi; V Savarino; G Celle
Journal:  Int J Pancreatol       Date:  1993-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.